News & Events

News Release Details

Expensify Announces Third Quarter 2021 Results

December 16, 2021

Increased revenues 72.6% year-over-year, introduced Free Plan with unparalleled functionality, and announced up to 2% cash back on all Expensify Card spend

PORTLAND, Ore.--(BUSINESS WIRE)--Dec. 16, 2021-- Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today announced results for its quarter ended September 30, 2021.

“The biggest news coming out of Q3 was the launch of our Free Plan for SMBs. It offers all the basics of Expensify for free – including corporate cards with up to 2% cash back, reimbursements, bill pay, invoicing, and travel booking – so teams don't have to worry about their back office while they grow their business,” said David Barrett, founder and CEO of Expensify. “We're especially excited to watch our Free Plan spread naturally across organizations as a result of our viral, bottom-up business model and the immense greenfield opportunity that still remains in our target market.”

“We saw strong paid member growth in Q3 as SMBs continue to bounce back from the pandemic, business-wise,” said Ryan Schaffer, CFO of Expensify. “Combine that with a 200% year-over-year increase in Expensify Card interchange and we're very confident in our ability to continue executing our long-term vision.”

Third Quarter 2021 Highlights

Financial:

  • Revenue was $37.4 million, an increase of 72.6% from the same period last year.
  • An IPO-related bonus expense of $26.3 million impacted net (loss) income and Adjusted EBITDA.
  • Net loss was $(6.3) million, compared to $(6.9) million for the same period last year. This was due to the IPO-related bonus.
    • However, Non-GAAP net income (excluding the IPO-related bonus) was $19.9 million.
  • Adjusted EBITDA was $(6.5) million, compared to $7.4 million for the same period last year. The decrease was due to the IPO-related bonus.
    • Adjusted EBITDA excluding the IPO-related bonus was $19.8 million.
  • Operating cash flows were $34.6 million.

Business:

  • Paid members saw the biggest uptick in Q3 since the onset of the COVID-19 pandemic in March 2020. Average monthly paid members increased to 667 thousand, up from 639 thousand in the previous quarter. This is attributed to an increase in marketing spend and the strengthening of SMBs as lockdown restrictions were lifted.
  • In September 2021, Expensify introduced the Free Plan, which allows members to roll out Expensify functionality across their businesses for free. The Expensify Card, expense management, next-day reimbursement, invoicing, bill pay, and travel booking are all included in the Free Plan.
  • The Expensify Card continues to perform well. Interchange from the card increased by 207% from the same period last year.
  • Cash back, a new Expensify Card benefit, launched in September 2021. Now, all Expensify members can get up to 2% cash back on all purchases using the Expensify Card.
  • Expensify.org selected 62 grassroots organizations as winners of the Community Justice Grant Challenge. All 62 organizations will be reimbursed up to $5,000 each to help fight injustice in their communities. From those 62 organizations, 10 were selected by community vote to be reimbursed up to $25,000 each.
  • In line with its continued commitment to ESG principles, Expensify reached carbon neutrality in 2021 and set a goal of Net Zero emissions by 2030.

Financial Outlook

Expensify's outlook statements are based on current expectations. The following statements are forward-looking and actual results could differ materially depending on market conditions and the factors set forth under “Forward-Looking Statements” below.

For the fiscal fourth quarter ending December 31, 2021, Expensify expects:

  • Revenue between $38.2 million and $39.2 million
  • Average monthly paid members between 673 thousand and 691 thousand.

Availability of Information on Expensify’s Website

Investors and others should note that Expensify routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Expensify Investor Relations website at https://ir.expensify.com. While not all of the information that the Company posts to its Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Expensify to review the information that it shares on its Investor Relations website.

Conference Call

Expensify will host a video call to discuss the results at 2:00 p.m. Pacific Time today. The video call information is available on Expensify’s Investor Relations website at https://ir.expensify.com. A replay of the call will be available on the site for three months.

Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), we provide certain non-GAAP financial measures, including Adjusted EBITDA, Adjusted EBITDA excluding the IPO-related bonus, and Non-GAAP net income.

We believe our non-GAAP financial measures are useful in evaluating our business, measuring our performance, identifying trends affecting our business, formulating business plans and making strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled metrics or measures presented by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP is at the end of this press release.

We define Adjusted EBITDA as net income from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization and stock based compensation.

We define Adjusted EBITDA excluding the IPO-related bonus as net income from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization, stock based compensation, and IPO-related bonus costs.

We define Non-GAAP net income as GAAP net income excluding the IPO-related bonus costs.

The tables at the end of the Financial Statements provide reconciliations to the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.

Forward-Looking Statements

Forward-looking statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. These statements include statements regarding our strategy, future financial condition, future operations, projected costs, prospects, plans, objectives of management and expected market growth and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the effects of the COVID-19 pandemic and the end of the COVID-19 pandemic on our business, results of operations and financial condition, and the global economy generally; our expectations regarding our financial performance and future operating performance; our ability to attract and retain members, expand usage of our platform, sell subscriptions to our platform and convert individuals and organizations into paying customers; the timing and success of new features, integrations, capabilities and enhancements by us, or by competitors to their products, or any other changes in the competitive landscape of our market; the amount and timing of operating expenses and capital expenditures that we may incur to maintain and expand our business and operations to remain competitive; the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs; our ability to make required payments under and to comply with the various requirements of our current and future indebtedness; our ability to effectively manage our exposure to fluctuations in foreign currency exchange rates; the increased expenses associated with being a public company; the size of our addressable markets, market share and market trends; anticipated trends, developments and challenges in our industry, business and the highly competitive markets in which we operate; our expectations regarding our income tax liabilities and the adequacy of our reserves; our ability to effectively manage our growth and expand our infrastructure and maintain our corporate culture; our ability to identify, recruit and retain skilled personnel, including key members of senior management; the safety, affordability and convenience of our platform and our offerings; our ability to successfully defend litigation brought against us; our ability to successfully identify, manage and integrate any existing and potential acquisitions of businesses, talent, technologies or intellectual property; general economic conditions in either domestic or international markets, including the societal and economic impact of the COVID-19 pandemic, and geopolitical uncertainty and instability; our protections against security breaches, technical difficulties, or interruptions to our platform; our ability to maintain, protect and enhance our intellectual property; and other risks discussed in our filings with the SEC. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. We caution you not to place undue reliance on any forward-looking statements, which are made only as of the date of this press release. We do not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable law. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

About Expensify

Expensify is a payments superapp that helps individuals and businesses around the world simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app. All free. Whether you own a small business, manage a team, or close the books for your clients, Expensify makes it easy so you have more time to focus on what really matters.

 

Expensify, Inc.

Consolidated Balance Sheets

(unaudited, in thousands, except share and per share data)

 

As of September 30,

 

As of December 31,

 

2021

 

2020

Assets

 

 

 

Cash and cash equivalents

$

68,058

 

 

 

$

34,401

 

 

Accounts receivable, net

13,608

 

 

 

10,024

 

 

Settlement assets

25,107

 

 

 

14,308

 

 

Prepaid expenses

3,813

 

 

 

927

 

 

Related party loan receivable, current

824

 

 

 

600

 

 

Other current assets

11,817

 

 

 

3,404

 

 

Total current assets

123,227

 

 

 

63,664

 

 

Capitalized software, net

6,607

 

 

 

3,722

 

 

Property and equipment, net

16,335

 

 

 

15,363

 

 

Lease right-of-use assets

2,588

 

 

 

3,733

 

 

Deferred tax assets, net

418

 

 

 

418

 

 

Related party loan receivable, non-current

 

 

 

 

 

Other assets

712

 

 

 

833

 

 

Total assets

$

149,887

 

 

 

$

87,733

 

 

Liabilities, convertible preferred stock and stockholders' deficit

Accounts payable

$

1,998

 

 

 

$

2,328

 

 

Accrued expenses and other liabilities

23,200

 

 

 

3,535

 

 

Borrowings under line of credit

15,000

 

 

 

15,000

 

 

Current portion of long-term debt, net of issuance costs

547

 

 

 

2,454

 

 

Lease liabilities, current

1,540

 

 

 

1,575

 

 

Settlement liabilities

25,007

 

 

 

14,308

 

 

Total current liabilities

67,292

 

 

 

39,200

 

 

Lease liabilities, non-current

1,192

 

 

 

2,350

 

 

Deferred tax liabilities, net

916

 

 

 

916

 

 

Other liabilities

405

 

 

 

877

 

 

Long-term debt, net of issuance costs

52,093

 

 

 

30,321

 

 

Total liabilities

121,898

 

 

 

73,664

 

 

Commitments and contingencies (Note 12)

 

 

 

Convertible preferred stock, par value $0.0001; 4,203,139 shares authorized, issued and outstanding at September 30, 2021 and December 31, 2020 (aggregate liquidation preference of $24,929,457 at September 30, 2021 and December 31, 2020

45,105

 

 

 

45,105

 

 

Stockholders' deficit:

 

 

 

Common stock, par value $0.0001; 95,000,000 shares authorized: 36,240,800 and 29,366,940 shares issued and outstanding at September 30, 2021 and December 31, 2020 respectively

 

 

 

 

 

Additional paid-in capital

27,416

 

 

 

21,312

 

 

Subscriptions receivable (including accrued interest of $0)

(513

)

 

 

 

 

Accumulated deficit

(44,019

)

 

 

(52,348

)

 

Total stockholders' deficit

(17,116

)

 

 

(31,036

)

 

Total liabilities, convertible preferred stock and stockholders' deficit

$

149,887

 

 

 

$

87,733

 

 

 

 

 

 

 

Expensify, Inc.

Consolidated Statements of Income

(unaudited, in thousands, except share and per share data)

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

2021

 

2020

 

2021

 

2020

Revenue

$

37,447

 

 

 

$

21,694

 

 

 

$

102,471

 

 

 

$

62,335

 

 

Cost of revenue, net

18,197

 

 

 

8,443

 

 

 

33,768

 

 

 

23,881

 

 

Gross margin

19,250

 

 

 

13,251

 

 

 

68,703

 

 

 

38,454

 

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

2,167

 

 

 

2,268

 

 

 

8,138

 

 

 

4,645

 

 

General and administrative

18,333

 

 

 

14,579

 

 

 

35,827

 

 

 

24,717

 

 

Sales and marketing

7,608

 

 

 

1,491

 

 

 

14,555

 

 

 

7,814

 

 

Total operating expenses

28,108

 

 

 

18,338

 

 

 

58,520

 

 

 

37,176

 

 

(Loss) income from operations

(8,858

)

 

 

(5,087

)

 

 

10,183

 

 

 

1,278

 

 

Interest and other expenses, net

(1,054

)

 

 

(646

)

 

 

(2,560

)

 

 

(2,160

)

 

(Loss) income before income taxes

(9,912

)

 

 

(5,733

)

 

 

7,623

 

 

 

(882

)

 

Benefit (provision) for income taxes

3,567

 

 

 

(1,205

)

 

 

706

 

 

 

(2,570

)

 

Net (loss) income

$

(6,345

)

 

 

$

(6,938

)

 

 

$

8,329

 

 

 

$

(3,452

)

 

 

 

 

 

 

 

 

 

Less: income allocated to participating securities

 

 

 

 

 

 

(5,625

)

 

 

 

 

Net (loss) income attributable to common stockholders

$

(6,345

)

 

 

$

(6,938

)

 

 

$

2,704

 

 

 

$

(3,452

)

 

Net (loss) income per share attributable to common stockholders:

 

 

 

 

 

 

 

Basic

$

(0.18

)

 

 

$

(0.25

)

 

 

$

0.09

 

 

 

$

(0.13

)

 

Diluted

$

(0.18

)

 

 

$

(0.25

)

 

 

$

0.07

 

 

 

$

(0.13

)

 

Weighted-average shares of common stock used to compute net (loss) income per share attributable to common stockholders:

 

 

 

 

 

 

 

Basic

34,490,860

 

 

 

27,951,536

 

 

 

31,301,387

 

 

 

27,095,925

 

 

Diluted

34,490,860

 

 

 

27,951,536

 

 

 

41,452,880

 

 

 

27,095,925

 

 

 

 

 

 

 

 

 

 

 

Expensify, Inc.

Consolidated Statements of Cash Flows

(unaudited, in thousands)

 

 

Nine months ended September 30,

 

2021

 

2020

Cash flows from operating activities:

 

 

 

Net income (loss)

$

8,329

 

 

 

$

(3,452

)

 

Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:

 

 

 

Depreciation and amortization

3,732

 

 

 

2,353

 

 

Reduction of operating lease right-of-use assets

552

 

 

 

1,120

 

 

Loss on impairment, receivables and sale or disposal of equipment

283

 

 

 

91

 

 

Stock-based compensation

2,495

 

 

 

12,951

 

 

Amortization of debt issuance costs

23

 

 

 

24

 

 

Deferred tax assets

 

 

 

2,304

 

 

Changes in assets and liabilities:

 

 

 

Accounts receivable

(3,865

)

 

 

(229

)

 

Related party loan receivables

(224

)

 

 

 

 

Settlement assets

(3,344

)

 

 

312

 

 

Prepaid expenses

(2,886

)

 

 

(291

)

 

Other current assets

1,212

 

 

 

(934

)

 

Other assets

120

 

 

 

(287

)

 

Accounts payable

(330

)

 

 

(1,563

)

 

Accrued expenses and other liabilities

18,870

 

 

 

162

 

 

Operating lease liabilities

(614

)

 

 

(1,179

)

 

Settlement liabilities

10,699

 

 

 

(16,084

)

 

Other liabilities

(472

)

 

 

310

 

 

Net cash provided (used) by operating activities

34,580

 

 

 

(4,392

)

 

Cash flows from investing activities:

 

 

 

Purchase of property and equipment

(2,602

)

 

 

(1,857

)

 

Software development costs

(4,397

)

 

 

(1,051

)

 

Net cash used by investing activities

(6,999

)

 

 

(2,908

)

 

Cash flows from financing activities:

 

 

 

Principal payments of finance leases

(579

)

 

 

(617

)

 

Principal payments of term loan

(25,157

)

 

 

(92

)

 

Principal payments of line of credit

 

 

 

(1,000

)

 

Proceeds from line of credit

 

 

 

9,613

 

 

Proceeds from term loan

45,000

 

 

 

 

 

Payments of deferred offering costs

(4,796

)

 

 

 

 

Vesting of restricted common stock

234

 

 

 

 

 

Proceeds from issuance of common stock on exercise of stock options

2,862

 

 

 

559

 

 

Net cash provided by financing activities

17,564

 

 

 

8,463

 

 

Net increase in cash and cash equivalents

45,145

 

 

 

1,163

 

 

Cash and cash equivalents and restricted cash, beginning of period

46,878

 

 

 

34,801

 

 

Cash and cash equivalents and restricted cash, end of period

$

92,023

 

 

 

$

35,964

 

 

Supplemental disclosure of cash flow information:

 

 

 

Cash paid for interest

$

2,182

 

 

 

$

2,186

 

 

Cash paid for income taxes

$

6,910

 

 

 

$

101

 

 

Noncash investing and financing items:

 

 

 

Right-of-use assets acquired with lease liabilities

$

 

 

 

$

1,260

 

 

Accrued deferred offering costs

$

795

 

 

 

$

 

 

Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets

 

 

 

Cash and cash equivalents

$

68,058

 

 

 

$

25,881

 

 

Restricted cash included in other current assets

5,989

 

 

 

1,666

 

 

Restricted cash included in other assets

47

 

 

 

45

 

 

Restricted cash included in settlement assets

17,929

 

 

 

8,372

 

 

Total cash, cash equivalents and restricted cash

$

92,023

 

 

 

$

35,964

 

 

 

 

 

 

 

Expensify, Inc.

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited, in thousands)

Adjusted EBITDA

 

Three months ended September 30,

 

2021

 

2020

Net (loss) income

$

(6,345

)

 

 

$

(6,938

)

 

Add:

 

 

 

(Benefit) provision for income taxes

(3,567

)

 

 

1,205

 

 

Interest and other expenses, net

1,054

 

 

 

646

 

 

Depreciation and amortization

1,438

 

 

 

744

 

 

Stock-based compensation

897

 

 

 

11,765

 

 

Adjusted EBITDA

$

(6,523

)

 

 

$

7,422

 

 

 

Adjusted EBITDA Excluding the IPO-Related Bonus

 

Three months ended September 30,

 

2021

 

2020

Net (loss) income

$

(6,345

)

 

 

$

(6,938

)

 

Add:

 

 

 

(Benefit) provision for income taxes

(3,567

)

 

 

1,205

 

 

Interest and other expenses, net

1,054

 

 

 

646

 

 

Depreciation and amortization

1,438

 

 

 

744

 

 

Stock-based compensation

897

 

 

 

11,765

 

 

IPO Related Bonuses

26,287

 

 

 

 

 

Adjusted EBITDA Excluding the IPO-Related Bonus

$

19,764

 

 

 

$

7,422

 

 

 

Non-GAAP Net Income

 

Three months ended September 30,

 

2021

 

2020

Net (loss) income

$

(6,345

)

 

 

$

(6,938

)

 

Add:

 

 

 

IPO Related Bonuses

26,287

 

 

 

 

 

Non-GAAP Net (loss) income

$

19,942

 

 

 

$

(6,938

)

 

 

 

 

 

 

Investor Relations Contact
Nick Tooker
investors@expensify.com

Press Contact
James Dean
press@expensify.com

Source: Expensify, Inc.